News | March 20, 2024
             
           AstraZeneca buys biopharmaceutical company Fusion
To accelerate the development of next-generation radioconjugates to treat cancer
To accelerate the development of next-generation radioconjugates to treat cancer
 
        Subscribe To Our Newsletter & Stay Updated